Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy.

Koguchi, Dai; Matsumoto, Kazumasa; Shimizu, Yuriko; Kobayashi, Momoko; Hirano, Shuhei; Ikeda, Masaomi; Sato, Yuichi; Iwamura, Masatsugu.

Afiliação

Koguchi D; Department of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato Minami-ku Sagamihara, Kanagawa 252-0374, Japan.
Matsumoto K; Department of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato Minami-ku Sagamihara, Kanagawa 252-0374, Japan.
Shimizu Y; Department of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato Minami-ku Sagamihara, Kanagawa 252-0374, Japan.
Kobayashi M; Department of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato Minami-ku Sagamihara, Kanagawa 252-0374, Japan.
Hirano S; Department of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato Minami-ku Sagamihara, Kanagawa 252-0374, Japan.
Ikeda M; Department of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato Minami-ku Sagamihara, Kanagawa 252-0374, Japan.
Sato Y; Department of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato Minami-ku Sagamihara, Kanagawa 252-0374, Japan.
Iwamura M; Department of Urology, Kitasato University School of Medicine, 1-15-1 Kitasato Minami-ku Sagamihara, Kanagawa 252-0374, Japan.

Cancers (Basel) ; 13(8)2021 Apr 09.

Article em En | MEDLINE | ID: mdl-33918555